Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Enoxaparin and Fondaparinux Sodium

  • First published: 23 December 2017
  • Last modified: 23 December 2017
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Authority ID:
AA20671
Publication date:
23 December 2017
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This framework is awarded for the supply of Fondaparinux Sodium in a range of presentations to health boards across NHS Scotland.

Each product line is treated as an individual Lot and is awarded on a line by line basis. Each lot is awarded as an un-ranked multi supplier framework agreement.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting authority

I.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Contact person: Hazel Johnstone

Telephone: +44 1698794410

E-mail: hazel.johnstone@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Enoxaparin and Fondaparinux Sodium

Reference number: NP46017

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

This framework agreement is for the supply of Enoxaparin and Fondaparinux Sodium to health boards across NHS Scotland.

The framework agreement is awarded as an un-ranked multi supplier framework on a line by line basis for each lot.

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 4 654 377.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

Enoxaparin Sodium

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UKM


Main site or place of performance:

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

II.2.4) Description of the procurement

This framework is awarded for the supply of Enoxaparin Sodium in a range of presentations to health boards across NHS Scotland.

Each product line is treated as an individual lot and is awarded on a line by line basis. Each Lot is awarded as an un-ranked multi supplier framework agreement.

II.2.5) Award criteria

Quality criterion: Integral Needle Safety Device / Weighting: 5

Quality criterion: Range of Presentations / Weighting: 10

Price / Weighting:  85

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Fondaparinux Sodium

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UKM


Main site or place of performance:

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to New Public Bodies (joint working) Scotland Act 2014.

II.2.4) Description of the procurement

This framework is awarded for the supply of Fondaparinux Sodium in a range of presentations to health boards across NHS Scotland.

Each product line is treated as an individual Lot and is awarded on a line by line basis. Each lot is awarded as an un-ranked multi supplier framework agreement.

II.2.5) Award criteria

Quality criterion: Integral Needle Safety Device / Weighting: 5

Quality criterion: Range of Presentations / Weighting: 10

Price / Weighting:  85

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2017/S 178-364174

Section V: Award of contract

Lot No: 1

Title: Enoxaparin Sodium

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

28/11/2017

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: Yes

V.2.3) Name and address of the contractor

ROVI Biotech Ltd

Davis House, 4th Floor, Robert Street

Croydon

CR0 1QQ

UK

Telephone: +44 7557673805

NUTS: UK

The contractor is an SME: Yes

V.2.3) Name and address of the contractor

Intrapharm Laboratories Ltd

The Granary, The Courtyard Barns, Choke Lane,

Maidenhead

SL6 6PT

UK

Telephone: +44 1908933982

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 4 279 077.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Fondaparinux Sodium

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

28/11/2017

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: Yes

V.2.3) Name and address of the contractor

Aspen Pharma Ireland Ltd

12/13 Exchange place, Custom House Docks

Dublin

dublin 1

IE

Telephone: +44 7879428644

NUTS: IE

The contractor is an SME: No

V.2.3) Name and address of the contractor

Dr Reddy's Laboratories (UK) Ltd

6 Riverview Road

Beverley

HU17 0LD

UK

Telephone: +44 7387020187

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 375 300.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

The total value in Section II.1.7 and V.2.4 refers to the 12 months initial duration of the framework agreement and the option to extend for 2 further periods of up to 12 months.

(SC Ref:522759).

VI.4) Procedures for review

VI.4.1) Review body

The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS")

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Telephone: +44 1698794410

Internet address(es)

URL: http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts(Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

VI.5) Date of dispatch of this notice

21/12/2017

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
hazel.johnstone@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.